Suppr超能文献

用于小鼠模型功能性血管组织工程的小直径可生物降解支架

Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model.

作者信息

Roh Jason D, Nelson Gregory N, Brennan Matthew P, Mirensky Tamar L, Yi Tai, Hazlett Tyrone F, Tellides George, Sinusas Albert J, Pober Jordan S, Saltzman W M, Kyriakides Themis R, Breuer Christopher K

机构信息

Yale University School of Medicine, Interdepartmental Program in Vascular Biology and Therapeutics, New Haven, CT 06510, USA.

出版信息

Biomaterials. 2008 Apr;29(10):1454-63. doi: 10.1016/j.biomaterials.2007.11.041. Epub 2007 Dec 27.

Abstract

The development of neotissue in tissue engineered vascular grafts remains poorly understood. Advances in mouse genetic models have been highly informative in the study of vascular biology, but have been inaccessible to vascular tissue engineers due to technical limitations on the use of mouse recipients. To this end, we have developed a method for constructing sub-1mm internal diameter (ID) biodegradable scaffolds utilizing a dual cylinder chamber molding system and a hybrid polyester sealant scaled for use in a mouse model. Scaffolds constructed from either polyglycolic acid or poly-l-lactic acid nonwoven felts demonstrated sufficient porosity, biomechanical profile, and biocompatibility to function as vascular grafts. The scaffolds implanted as either inferior vena cava or aortic interposition grafts in SCID/bg mice demonstrated excellent patency without evidence of thromboembolic complications or aneurysm formation. A foreign body immune response was observed with marked macrophage infiltration and giant cell formation by post-operative week 3. Organized vascular neotissue, consisting of endothelialization, medial generation, and collagen deposition, was evident within the internal lumen of the scaffolds by post-operative week 6. These results present the ability to create sub-1mm ID biodegradable tubular scaffolds that are functional as vascular grafts, and provide an experimental approach for the study of vascular tissue engineering using mouse models.

摘要

组织工程血管移植物中新生组织的发育仍知之甚少。小鼠遗传模型的进展在血管生物学研究中提供了丰富的信息,但由于小鼠受体使用上的技术限制,血管组织工程师无法利用这些模型。为此,我们开发了一种方法,利用双圆柱腔成型系统和按比例用于小鼠模型的混合聚酯密封剂来构建内径小于1毫米的可生物降解支架。由聚乙醇酸或聚左旋乳酸非织造毡构建的支架表现出足够的孔隙率、生物力学特性和生物相容性,可作为血管移植物发挥作用。在SCID/bg小鼠中作为下腔静脉或主动脉间置移植物植入的支架显示出极好的通畅性,没有血栓栓塞并发症或动脉瘤形成的迹象。术后第3周观察到异物免疫反应,有明显的巨噬细胞浸润和巨细胞形成。术后第6周,在支架的内腔内可见有组织的血管新生组织,包括内皮化、中层生成和胶原沉积。这些结果表明能够创建内径小于1毫米的可生物降解管状支架,其可作为血管移植物发挥功能,并为使用小鼠模型研究血管组织工程提供了一种实验方法。

相似文献

1
Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model.
Biomaterials. 2008 Apr;29(10):1454-63. doi: 10.1016/j.biomaterials.2007.11.041. Epub 2007 Dec 27.
2
Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts.
J Thorac Cardiovasc Surg. 2012 Mar;143(3):696-703. doi: 10.1016/j.jtcvs.2011.06.046. Epub 2012 Jan 12.
3
Evaluation of remodeling process in small-diameter cell-free tissue-engineered arterial graft.
J Vasc Surg. 2015 Sep;62(3):734-43. doi: 10.1016/j.jvs.2014.03.011. Epub 2014 Apr 16.
5
Implantation of inferior vena cava interposition graft in mouse model.
J Vis Exp. 2014 Jun 4(88):51632. doi: 10.3791/51632.
6
Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts.
Tissue Eng Part A. 2018 Jan;24(1-2):135-144. doi: 10.1089/ten.TEA.2017.0044. Epub 2017 Jun 13.
7
Vascular tissue engineering of small-diameter blood vessels: reviewing the electrospinning approach.
J Tissue Eng Regen Med. 2015 Aug;9(8):861-88. doi: 10.1002/term.1697. Epub 2013 Jan 31.

引用本文的文献

1
Bioengineered Bile Duct for Liver Regenerative Medicine and Bile Duct Reconstruction.
JGH Open. 2025 Aug 12;9(8):e70254. doi: 10.1002/jgh3.70254. eCollection 2025 Aug.
3
Mapping the blueprint of artificial blood vessels research: a bibliometric analysis.
Int J Surg. 2025 Jan 1;111(1):1014-1031. doi: 10.1097/JS9.0000000000001877.
4
Hemodynamics and Wall Mechanics of Vascular Graft Failure.
Arterioscler Thromb Vasc Biol. 2024 May;44(5):1065-1085. doi: 10.1161/ATVBAHA.123.318239. Epub 2024 Apr 4.
5
Implanted Tissue-Engineered Vascular Graft Cell Isolation with Single-Cell RNA Sequencing Analysis.
Tissue Eng Part C Methods. 2023 Feb;29(2):72-84. doi: 10.1089/ten.TEC.2022.0189.
6
Tissue Engineering of Vascular Grafts: A Case Report From Bench to Bedside and Back.
Arterioscler Thromb Vasc Biol. 2023 Mar;43(3):399-409. doi: 10.1161/ATVBAHA.122.318236. Epub 2023 Jan 12.
9
Foreign body response to synthetic polymer biomaterials and the role of adaptive immunity.
Biomed Mater. 2022 Mar 4;17(2). doi: 10.1088/1748-605X/ac5574.
10
Zoledronate alters natural progression of tissue-engineered vascular grafts.
FASEB J. 2021 Oct;35(10):e21849. doi: 10.1096/fj.202001606RR.

本文引用的文献

1
Principles of genetic murine models for cardiac disease.
Circulation. 2007 Feb 13;115(6):792-9. doi: 10.1161/CIRCULATIONAHA.106.682534.
2
Humanized mice in translational biomedical research.
Nat Rev Immunol. 2007 Feb;7(2):118-30. doi: 10.1038/nri2017.
3
Limits to the durability of arterial elastic tissue.
Biomaterials. 2007 Apr;28(11):2021-31. doi: 10.1016/j.biomaterials.2007.01.016. Epub 2007 Jan 10.
5
6
Development of a model system for preliminary evaluation of tissue-engineered vascular conduits.
J Pediatr Surg. 2006 Apr;41(4):787-91. doi: 10.1016/j.jpedsurg.2006.02.019.
7
The mechanical properties of infrainguinal vascular bypass grafts: their role in influencing patency.
Eur J Vasc Endovasc Surg. 2006 Jun;31(6):627-36. doi: 10.1016/j.ejvs.2006.01.006. Epub 2006 Mar 2.
8
Human tissue-engineered blood vessels for adult arterial revascularization.
Nat Med. 2006 Mar;12(3):361-5. doi: 10.1038/nm1364. Epub 2006 Feb 19.
9
Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells.
J Thorac Cardiovasc Surg. 2005 Jun;129(6):1330-8. doi: 10.1016/j.jtcvs.2004.12.047.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验